Hamilton Lane Advisors LLC Syros Pharmaceuticals, Inc. Transaction History

Hamilton Lane Advisors LLC

  • $122 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 31, 2018
SELL
$10.16 - $13.65 $104,739 - $140,717
-10,309 Closed
0 $0
Q4 2017

Jan 17, 2018
SELL
$8.45 - $17.48 $84,500 - $174,800
-10,000 Reduced 49.24%
10,309 $100,000
Q3 2017

Oct 16, 2017
BUY
$13.52 - $23.75 $274,577 - $482,338
20,309
20,309 $299,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email